Sarepta Therapeutics, Inc. — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
13F-HR
144
3
3/A
4
4/A
424B3
424B4
424B5
424B7
425
5
8-A12B
8-A12G
8-K
8-K/A
8-K12B
ARS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
EFFECT
FWP
POS AM
POSASR
PRE 14A
REGDEX
RW
S-1
S-3
S-3/A
S-3ASR
S-4
S-4/A
S-8
S-8 POS
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-T
SC TO-T/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-002227 | Mar 27, 2026 | — |
| 4 | 4 | 0001193125-26-106710 | Mar 13, 2026 | Mar 11, 2026 |
| 4 | 4 | 0001193125-26-106706 | Mar 13, 2026 | Mar 11, 2026 |
| 4 | 4 | 0001193125-26-106703 | Mar 13, 2026 | Mar 11, 2026 |
| 4 | 4 | 0001193125-26-106701 | Mar 13, 2026 | Mar 12, 2026 |
| 4 | 4 | 0001193125-26-106697 | Mar 13, 2026 | Mar 11, 2026 |
| 144 | — | 0001950047-26-002538 | Mar 12, 2026 | — |
| 4 | 4 | 0001193125-26-102710 | Mar 11, 2026 | Mar 9, 2026 |
| 4 | 4 | 0001193125-26-102708 | Mar 11, 2026 | Mar 9, 2026 |
| 4 | 4 | 0001193125-26-102703 | Mar 11, 2026 | Mar 9, 2026 |
| 4 | 4 | 0001193125-26-102701 | Mar 11, 2026 | Mar 9, 2026 |
| 4 | 4 | 0001193125-26-089439 | Mar 3, 2026 | Mar 2, 2026 |
| 4 | 4 | 0001193125-26-089433 | Mar 3, 2026 | Mar 2, 2026 |
| 4 | 4 | 0001193125-26-089432 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | 4 | 0001193125-26-089425 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | 4 | 0001193125-26-084265 | Mar 2, 2026 | Feb 26, 2026 |
| 10-K | 10-K | 0001193125-26-084144 | Mar 2, 2026 | Dec 31, 2025 |
| 4 | 4 | 0001193125-26-083674 | Feb 27, 2026 | Feb 25, 2026 |
| 4 | 4 | 0001193125-26-083671 | Feb 27, 2026 | Feb 25, 2026 |
| 8-K | 8-K | 0001193125-26-072064 | Feb 25, 2026 | — |
| 8-K | 8-K | 0001193125-26-071566 | Feb 25, 2026 | — |
| SCHEDULE 13G | — | 0001167557-26-000049 | Feb 13, 2026 | — |
| 13F-HR | — | 0001193125-26-049427 | Feb 13, 2026 | Dec 31, 2025 |
| 4 | 4 | 0001193125-26-029895 | Jan 29, 2026 | — |
| 4 | 4 | 0001193125-26-029893 | Jan 29, 2026 | Jan 27, 2026 |
| SCHEDULE 13G/A | — | 0002012383-26-000787 | Jan 21, 2026 | — |
| 8-K | 8-K | 0001193125-26-010116 | Jan 12, 2026 | — |
| 4 | 4 | 0001193125-25-326980 | Dec 19, 2025 | Dec 18, 2025 |
| 8-K | 8-K | 0001193125-25-326969 | Dec 19, 2025 | Dec 18, 2025 |
| 4 | 4 | 0001193125-25-325383 | Dec 18, 2025 | Dec 16, 2025 |
| 144 | — | 0001950047-25-010429 | Dec 16, 2025 | — |
| 8-K | 8-K | 0001193125-25-315032 | Dec 11, 2025 | Dec 10, 2025 |
| 4 | 4 | 0001193125-25-314652 | Dec 10, 2025 | Dec 1, 2025 |
| 4 | 4 | 0001193125-25-313184 | Dec 9, 2025 | Dec 7, 2025 |
| 8-K | 8-K | 0001193125-25-310588 | Dec 8, 2025 | Dec 7, 2025 |
| 4 | 4 | 0001193125-25-305662 | Dec 2, 2025 | Nov 28, 2025 |
| 4 | 4 | 0001193125-25-288556 | Nov 19, 2025 | Nov 17, 2025 |
| SCHEDULE 13G/A | — | 0001104659-25-112507 | Nov 14, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-269436 | Nov 6, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-262591 | Nov 3, 2025 | — |
| SCHEDULE 13G/A | — | 0000932471-25-001161 | Sep 8, 2025 | — |
| 4 | 4 | 0001193125-25-197425 | Sep 5, 2025 | Sep 3, 2025 |
| 4 | 4 | 0001193125-25-197424 | Sep 5, 2025 | Sep 3, 2025 |
| 4 | 4 | 0001193125-25-197423 | Sep 5, 2025 | Sep 3, 2025 |
| 4 | 4 | 0001193125-25-197422 | Sep 5, 2025 | Sep 3, 2025 |
| 8-K | 8-K | 0001193125-25-192794 | Aug 29, 2025 | Aug 28, 2025 |
| 8-K | 8-K | 0001193125-25-184625 | Aug 21, 2025 | Aug 18, 2025 |
| SCHEDULE 13D/A | — | 0000950170-25-109461 | Aug 15, 2025 | — |
| 8-K | 8-K | 0001193125-25-179819 | Aug 13, 2025 | Aug 12, 2025 |
| SCHEDULE 13G/A | — | 0001562230-25-000112 | Aug 13, 2025 | — |